Code: 04579332

Genome-Based Diagnostics

Name: Genome-Based Diagnostics
Brand: National Academies Press
SKU: 04579332
Price: 40.59 EUR
Availability: BackOrder

by Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy, Institute of Medicine

Language: English
Binding: Paperback
Number of pages: 104
Publisher: National Academies Press, 2012
More about this

40.59 €

RRP: 40.65 €

You save 0.06 €

Availability:

50/50

We think title might be available. Upon your order we will do our best to get it within 6 weeks.
We search the world

Availability alert

Add to wishlist

Wonder
17.42 € -18 %
Buy

Give this book as a present today

Order book and choose Gift Order.
We will send you book gift voucher at once. You can give it out to anyone.
Book will be send to donee, nothing more to care about.

Book gift voucher sample Read more

Availability alert

We will watch availability for you

Enter your e-mail address and once book will be available,
we will send you a message. It's that simple.

You get 102 loyalty points

Book synopsis

The sequencing of the human genome and the identification of associations between specific genetic variants and diseases have led to an explosion of genomic-based diagnostic tests. These tests have the potential to direct therapeutic interventions, predict risk or onset of disease, or detect residual disease. As research progresses and an increasing number of associations are found, further tests will be developed that can aid in providing personalized treatment options for patients. However, the adoption of genomic diagnostic tests by health care providers has been limited due to a lack of evidence regarding the clinical utility of many tests. Health funders and practitioners lack the data necessary to distinguish which tests can improve practice or the clinical settings in which tests will provide the greatest value. The Roundtable on Translating Genomic-Based Research for Health held a workshop in November 2010 to determine what evidence is needed and how it is viewed by different stakeholders in order to develop genomic diagnostic tests of clinical value. Genome-Based Diagnostics summarizes the presentations and discussions that took place throughout the workshop. Two presentations, in particular, sparked extensive discussion. One presentation proposed that all genomic diagnostic tests be reviewed and approved by the Food and Drug Administration. The other observed that venture capitalists are no longer investing substantially in the development of genomic diagnostic tests because of a lack of clarity surrounding regulatory and reimbursement pathways. Both presentations suggested the need for major changes in the systems used to develop, regulate, and reimburse genomic diagnostic tests. The report also presents the perspectives of different stakeholders in the development of genomic diagnostic tests. Each stakeholder group has a different set of needs and issues of importance, yet commonalities among them are apparent, such as the need to put patients and health outcomes at the center of discussion and action.

Book details

Book category Books in English Medicine Pre-clinical medicine: basic sciences Medical genetics

40.59 €

Full title: Genome-Based Diagnostics
Subtitle: Clarifying Pathways to Clinical Use: Workshop Summary
Author: Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy, Institute of Medicine
Language: English
Binding: Paperback
Number of pages: 104
EAN: 9780309253949
ISBN: 0309253942
ID: 04579332
Publisher: National Academies Press
Weight: 181 g
Dimensions: 229 × 152 × 10 mm
Date of publishing: 27. July 2012